Search Results - "DE CENSI, Andrea"

Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial by Bonelli, Luigina, Puntoni, Matteo, Gatteschi, Beatrice, Massa, Paolo, Missale, Guido, Munizzi, Francesco, Turbino, Laura, Villanacci, Vincenzo, De Censi, Andrea, Bruzzi, Paolo

“…Background Patients who undergo polypectomy are at increased risk of adenoma recurrence. The preventive potential of vitamins (A, C and E) and selenium…”
Get full text

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial by Gennari, Alessandra, Foca, Flavia, Zamarchi, Rita, Rocca, Andrea, Amadori, Dino, De Censi, Andrea, Bologna, Alessandra, Cavanna, Luigi, Gianni, Lorenzo, Scaltriti, Laura, Rossi, Elisabetta, Facchinetti, Antonella, Martini, Veronica, Bruzzi, Paolo, Nanni, Oriana

“…Purpose To evaluate the prognostic value of IGF-1R expression on circulating tumor cells (CTCs) in a prospective randomized clinical trial comparing…”
Get full text

Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy by Pastorino, Roberta, Basile, Michele, Tognetto, Alessia, Di Marco, Marco, Grossi, Adriano, Lucci-Cordisco, Emanuela, Scaldaferri, Franco, De Censi, Andrea, Federici, Antonio, Villari, Paolo, Genuardi, Maurizio, Ricciardi, Walter, Boccia, Stefania

“…Lynch syndrome (LS) is an autosomal dominant condition caused by pathogenic variants in mismatch repair (MMR) genes that predispose individuals to different…”
Get full text

Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report by Baiardi, Giammarco, Clavarezza, Matteo, Stella, Manuela, Casazza, Stefania, De Censi, Andrea, Mattioli, Francesca

“…Background Fluoropyrimidines (FPs) form still nowadays the backbone of chemotherapic schemes in colorectal cancer (CRC). Inter-patient variability of the…”
Get full text

Insulin-like growth factor-1 receptor and metastatic breast cancer outcome: results from the TransMYME trial by Gennari, Alessandra, Foca, Flavia, Zamarchi, Rita, Rocca, Andrea, Amadori, Dino, De Censi, Andrea, Bologna, Alessandra

“…Purpose To evaluate the prognostic value of IGF-1R expression on circulating tumor cells (CTCs) in a prospective randomized clinical trial comparing…”
Get full text

Insulin-like growth factor-1 receptor by Foca, Flavia, Bologna, Alessandra, Zamarchi, Rita, Gennari, Alessandra, Rocca, Andrea, Amadori, Dino, De Censi, Andrea

“…Purpose To evaluate the prognostic value of IGF-1R expression on circulating tumor cells (CTCs) in a prospective randomized clinical trial comparing…”
Get full text

TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study by Bignotti, Eliana, Simeon, Vittorio, Ardighieri, Laura, Kuhn, Elisabetta, Marchini, Sergio, Califano, Daniela, Cecere, Sabrina Chiara, Bugatti, Mattia, Spina, Anna, Scognamiglio, Giosuè, Paracchini, Lara, Russo, Daniela, Arenare, Laura, Tognon, Germana, Lorusso, Domenica, Beltrame, Luca, D'Incalci, Maurizio, Sartori, Enrico, De Censi, Andrea, Odicino, Franco, Perrone, Francesco, Chiodini, Paolo, Pignata, Sandro

“…To date, there are no biomarkers that define a patient subpopulation responsive to bevacizumab (BEV), an effective treatment option for advanced ovarian…”
Get full text

Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies by Gennari, Alessandra, Costa, Mauro, Puntoni, Matteo, Paleari, Laura, De Censi, Andrea, Sormani, Maria Pia, Provinciali, Nicoletta, Bruzzi, Paolo

“…The increasing practice of hormonal infertility treatments (HITs) raised concerns about their effects on breast cancer (BC) risk. Available evidence reported…”
Get full text

Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report by Pasquariello, Stefano, Clavarezza, Matteo, Piredda, Sabrina, Foppiani, Luca, Pesce, Giampaola, Antonucci, Giancarlo, De Censi, Andrea, Mattioli, Francesca

“…Drug-induced thrombocytopenia is an adverse reaction characterized by accelerated platelet destruction. The present study described a case of thrombocytopenia…”
Get full text

Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report by Pasquariello, Stefano, Clavarezza, Matteo, Piredda, Sabrina, Foppiani, Luca, Pesce, Giampaola, Antonucci, Giancarlo, De Censi, Andrea, Mattioli, Francesca

“…Drug-induced thrombocytopenia is an adverse reaction characterized by accelerated platelet destruction. The present study described a case of thrombocytopenia…”
Get full text

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab by Polano, Maurizio, Bedon, Luca, Dal Bo, Michele, Sorio, Roberto, Bartoletti, Michele, De Mattia, Elena, Cecchin, Erika, Pisano, Carmela, Lorusso, Domenica, Lissoni, Andrea Alberto, De Censi, Andrea, Cecere, Sabrina Chiara, Scollo, Paolo, Marchini, Sergio, Arenare, Laura, De Giorgi, Ugo, Califano, Daniela, Biagioli, Elena, Chiodini, Paolo, Perrone, Francesco, Pignata, Sandro, Toffoli, Giuseppe

“…Pharmacogenomics studies how genes influence a person's response to treatment. When complex phenotypes are influenced by multiple genetic variations with…”
Get full text

Early prediction of endocrine responsiveness in ER+/HER2 negative MBC: Pilot study with 18F-fluoroestradiol (18F-FES) CT/PET by Gennari, Alessandra, Brain, Etienne, De Censi, Andrea, Nanni, Oriana, Wuerstlein, Rachel, Frassoldati, Antonio, Cortes, Javier, Rossi, Valentina, Palleschi, Michela, Alberini, Jean-Louis, Matteucci, Federica, Piccardo, Arnoldo, Sacchetti, Gian Mauro, Ilhan, Harun, Ruffilli, Beatrice, Nardin, Simone, Monti, Manuela, Puntoni, Matteo, Boni, Luca, Harbeck, Nadia

“…1024 Background: Estrogen receptors (ER) are considered predictive biomarkers to identify ER+ MBC patients who would likely benefit from endocrine therapies…”
Get full text

Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) by Gori, Stefania, Puglisi, Fabio, Cinquini, Michela, Pappagallo, Giovanni, Frassoldati, Antonio, Biganzoli, Laura, Cortesi, Laura, Fiorentino, Alba, Angiolini, Catia, Tinterri, Corrado, De Censi, Andrea, Levaggi, Alessia, Del Mastro, Lucia

“…Premenopausal women with hormone receptor-positive early breast cancer are candidates for adjuvant endocrine therapy, as recommended by the major international…”
Get full text

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies by Lambertini, Matteo, Ceppi, Marcello, Cognetti, Francesco, Cavazzini, Giovanna, De Laurentiis, Michele, De Placido, Sabino, Michelotti, Andrea, Bisagni, Giancarlo, Durando, Antonio, Valle, Enrichetta, Scotto, Tiziana, De Censi, Andrea, Turletti, Anna, Benasso, Marco, Barni, Sandro, Montemurro, Filippo, Puglisi, Fabio, Levaggi, Alessia, Giraudi, Sara, Bighin, Claudia, Bruzzi, Paolo, Del Mastro, Lucia

“…Abstract Background No evidence exists to recommend a specific chemotherapy regimen in young breast cancer patients. We performed a pooled analysis of two…”
Get full text

A randomized presurgical trial of alternative dosing of exemestane in postmenopausal women with early-stage ER-positive breast cancer by De Censi, Andrea, Serrano, Davide, Gandini, Sara, Thomas, Parijatham S., Crew, Katherine D., Kumar, Nagi B., Lee, J. Jack, Veronesi, Paolo, Guerrieri-Gonzaga, Aliana, Johansson, Harriet, D'Amico, Mauro, Guasone, Flavio, Ertelsen, Bjorn-Erik, Mellgren, Gunnar, Bedrosian, Isabelle, Dimond, Eileen, Heckman-Stoddard, Brandy M., Szabo, Eva, Brown, Powel, Bonanni, Bernardo

“…519 Background: Successful therapeutic cancer prevention requires definition of the minimal effective dose of the proposed agent. Aromatase inhibitors…”
Get full text

Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes by Smith, Samuel G, Foy, Robbie, McGowan, Jennifer A, Kobayashi, Lindsay C, de Censi, Andrea, DeCensi, Andrea, Brown, Karen, Side, Lucy, Cuzick, Jack

“…The cancer strategy for England (2015-2020) recommends GPs prescribe tamoxifen for breast cancer primary prevention among women at increased risk. To…”
Get full text

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study by Daniele, Gennaro, Raspagliesi, Francesco, Scambia, Giovanni, Pisano, Carmela, Colombo, Nicoletta, Frezzini, Simona, Tognon, Germana, Artioli, Grazia, Gadducci, Angiolo, Lauria, Rossella, Ferrero, Annamaria, Cinieri, Saverio, De Censi, Andrea, Breda, Enrico, Scollo, Paolo, De Giorgi, Ugo, Lissoni, Andrea Alberto, Katsaros, Dionyssios, Lorusso, Domenica, Salutari, Vanda, Cecere, Sabrina Chiara, Zaccarelli, Eleonora, Nardin, Margherita, Bogani, Giorgio, Distefano, Mariagrazia, Greggi, Stefano, Piccirillo, Maria Carmela, Fossati, Roldano, Giannone, Gaia, Arenare, Laura, Gallo, Ciro, Perrone, Francesco, Pignata, Sandro

“…To explore the clinical and biological prognostic factors for advanced ovarian cancer patients receiving first-line treatment with carboplatin, paclitaxel, and…”
Get more information

Relationship between CYP2D6 genotype, tamoxifen metabolites, and adverse events, tumor biomarkers and breast cancer recurrence in a low-dose phase III trial in noninvasive disease by De Censi, Andrea, Johansson, Harriet Ann, Helland, Thomas, Puntoni, Matteo, Buttiron Webber, Tania, Macis, Debora, Aristarco, Valentina, Briata, Irene Maria, Serrano, Davide, D'Amico, Mauro, Bifulco, Ersilia, Hustad, Steinar, Søiland, Håvard, Bonanni, Bernardo, Mellgren, Gunnar

“…Abstract only 1553 Background: Low dose tamoxifen (T, 5 mg/d) given for 3 years halved recurrence in 500 women with non-invasive disease (DeCensi et al. JCO…”
Get full text

Endocrine therapy for ovarian cancer: A systematic review and meta-analysis of phase II studies by Paleari, Laura, Provinciali, Nicoletta, Puntoni, Matteo, Defferrari, Carlotta, Di Luca, Martina, Gorlero, Franco, De Censi, Andrea

“…Abstract only…”
Get full text

Factors modulating worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in postmenopausal hormone users by Rondanina, Gabriella, Puntoni, Matteo, Guerrieri-Gonzaga, Aliana, Marra, Domenico, Bonanni, Bernardo, De Censi, Andrea

“…Abstract only…”
Get full text